.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
UBS
Merck
Covington
Accenture
Daiichi Sankyo
Cipla
Fish and Richardson
Chinese Patent Office
Citi

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208686

« Back to Dashboard
NDA 208686 describes EPANED, which is a drug marketed by Silvergate Pharms and is included in two NDAs. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the EPANED profile page.

The generic ingredient in EPANED is enalapril maleate. There are twenty-seven drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the enalapril maleate profile page.

Summary for NDA: 208686

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 208686

Suppliers and Packaging for NDA: 208686

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EPANED
enalapril maleate
SOLUTION;ORAL 208686 NDA Silvergate Pharmaceuticals, Inc. 52652-4001 52652-4001-1 150 mL in 1 BOTTLE (52652-4001-1)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength1MG/ML
Approval Date:Sep 20, 2016TE:RLD:No
Patent:9,669,008Patent Expiration:Mar 25, 2036Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Fish and Richardson
QuintilesIMS
Cerilliant
Cipla
Farmers Insurance
Merck
Chinese Patent Office
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot